169 related articles for article (PubMed ID: 37929279)
21. Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats.
Komatsu T; Honda K; Kubota A; Kitazawa T; Hiraga T; Teraoka H
J Vet Med Sci; 2010 Dec; 72(12):1633-6. PubMed ID: 20661004
[TBL] [Abstract][Full Text] [Related]
22. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
Kimura S; Umeno M; Skoda RC; Meyer UA; Gonzalez FJ
Am J Hum Genet; 1989 Dec; 45(6):889-904. PubMed ID: 2574001
[TBL] [Abstract][Full Text] [Related]
23. Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.
Yue J; Miksys S; Hoffmann E; Tyndale RF
J Psychiatry Neurosci; 2008 Jan; 33(1):54-63. PubMed ID: 18197273
[TBL] [Abstract][Full Text] [Related]
24. Homology modeling of rat and human cytochrome P450 2D (CYP2D) isoforms and computational rationalization of experimental ligand-binding specificities.
Venhorst J; ter Laak AM; Commandeur JN; Funae Y; Hiroi T; Vermeulen NP
J Med Chem; 2003 Jan; 46(1):74-86. PubMed ID: 12502361
[TBL] [Abstract][Full Text] [Related]
25. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation.
Johansson I; Oscarson M; Yue QY; Bertilsson L; Sjöqvist F; Ingelman-Sundberg M
Mol Pharmacol; 1994 Sep; 46(3):452-9. PubMed ID: 7935325
[TBL] [Abstract][Full Text] [Related]
26. Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity.
Smith G; Modi S; Pillai I; Lian LY; Sutcliffe MJ; Pritchard MP; Friedberg T; Roberts GC; Wolf CR
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):783-92. PubMed ID: 9560305
[TBL] [Abstract][Full Text] [Related]
27. Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.
Zhou SF
Clin Pharmacokinet; 2009; 48(12):761-804. PubMed ID: 19902987
[TBL] [Abstract][Full Text] [Related]
28. The clinical effectiveness and cost-effectiveness of genotyping for CYP2D6 for the management of women with breast cancer treated with tamoxifen: a systematic review.
Fleeman N; Martin Saborido C; Payne K; Boland A; Dickson R; Dundar Y; Fernández Santander A; Howell S; Newman W; Oyee J; Walley T
Health Technol Assess; 2011 Sep; 15(33):1-102. PubMed ID: 21906462
[TBL] [Abstract][Full Text] [Related]
29. Equus caballus papillomavirus-2 (EcPV-2): an infectious cause for equine genital cancer?
Scase T; Brandt S; Kainzbauer C; Sykora S; Bijmholt S; Hughes K; Sharpe S; Foote A
Equine Vet J; 2010 Nov; 42(8):738-45. PubMed ID: 21039805
[TBL] [Abstract][Full Text] [Related]
30. First description of Theiler's disease-associated virus infection and epidemiological investigation of equine pegivirus and equine hepacivirus coinfection in Brazil.
Figueiredo AS; de Moraes MVDS; Soares CC; Chalhoub FLL; de Filippis AMB; Dos Santos DRL; de Almeida FQ; Godoi TLOS; de Souza AM; Burdman TR; de Lemos ERS; Dos Reis JKP; Cruz OG; Pinto MA
Transbound Emerg Dis; 2019 Jul; 66(4):1737-1751. PubMed ID: 31017727
[TBL] [Abstract][Full Text] [Related]
31. Ultrarapid hydroxylation of debrisoquine in a Swedish population. Analysis of the molecular genetic basis.
Dahl ML; Johansson I; Bertilsson L; Ingelman-Sundberg M; Sjöqvist F
J Pharmacol Exp Ther; 1995 Jul; 274(1):516-20. PubMed ID: 7616439
[TBL] [Abstract][Full Text] [Related]
32. Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment.
Mann A; Miksys S; Lee A; Mash DC; Tyndale RF
Neuropharmacology; 2008 Dec; 55(7):1147-55. PubMed ID: 18687346
[TBL] [Abstract][Full Text] [Related]
33. Modeling human cytochrome P450 2D6 metabolism and drug-drug interaction by a novel panel of knockout and humanized mouse lines.
Scheer N; Kapelyukh Y; McEwan J; Beuger V; Stanley LA; Rode A; Wolf CR
Mol Pharmacol; 2012 Jan; 81(1):63-72. PubMed ID: 21989258
[TBL] [Abstract][Full Text] [Related]
34. Cytochrome P450 CYP2D6 gene polymorphism and lung cancer susceptibility in Caucasians.
Legrand-Andréoletti M; Stücker I; Marez D; Galais P; Cosme J; Sabbagh N; Spire C; Cenée S; Lafitte JJ; Beaune P; Broly F
Pharmacogenetics; 1998 Feb; 8(1):7-14. PubMed ID: 9511176
[TBL] [Abstract][Full Text] [Related]
35. The First Report of Genetic Polymorphisms of the Equine
Won SY; Kim YC; Do K; Jeong BH
Animals (Basel); 2021 Sep; 11(9):. PubMed ID: 34573540
[TBL] [Abstract][Full Text] [Related]
36. Sex steroid hormones differentially regulate CYP2D in female wild-type and CYP2D6-humanized mice.
Konstandi M; Andriopoulou CE; Cheng J; Gonzalez FJ
J Endocrinol; 2020 May; 245(2):301-314. PubMed ID: 32171179
[TBL] [Abstract][Full Text] [Related]
37. Polymorphism at expressed DQ and DR loci in five common equine MHC haplotypes.
Miller D; Tallmadge RL; Binns M; Zhu B; Mohamoud YA; Ahmed A; Brooks SA; Antczak DF
Immunogenetics; 2017 Mar; 69(3):145-156. PubMed ID: 27889800
[TBL] [Abstract][Full Text] [Related]
38. Discriminative quantification of cytochrome P4502D6 and 2D7/8 pseudogene expression by TaqMan real-time reverse transcriptase polymerase chain reaction.
Endrizzi K; Fischer J; Klein K; Schwab M; Nüssler A; Neuhaus P; Eichelbaum M; Zanger UM
Anal Biochem; 2002 Jan; 300(2):121-31. PubMed ID: 11779102
[TBL] [Abstract][Full Text] [Related]
39. Alternative splicing of CYP2D mRNA in human breast tissue.
Huang Z; Fasco MJ; Kaminsky LS
Arch Biochem Biophys; 1997 Jul; 343(1):101-8. PubMed ID: 9210651
[TBL] [Abstract][Full Text] [Related]
40. Ethanol self-administration and nicotine treatment increase brain levels of CYP2D in African green monkeys.
Miller RT; Miksys S; Hoffmann E; Tyndale RF
Br J Pharmacol; 2014 Jun; 171(12):3077-88. PubMed ID: 24611668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
